Management of the highly HLA-sensitized patient. A novel role for intravenous gammaglobulin

[1] A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection [J]. TRANSPLANTATION, 2001, 71 (01) : 53 - 58

[2] DeMarco T, 1997, J HEART LUNG TRANSPL, V16, P360

[3] SUPPRESSION OF HLA-SPECIFIC ALLOANTIBODIES BY HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIG) - A POTENTIAL TOOL FOR TRANSPLANTATION OF IMMUNIZED PATIENTS [J]. TRANSPLANTATION, 1993, 56 (02) : 335 - 337

[4] GLOTZ D, 1995, TRANSPLANT P, V27, P1038

[5] JORDAN S C, 1991, Journal of the American Society of Nephrology, V2, P803

[6] Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action [J]. TRANSPLANTATION, 1998, 66 (06) : 800 - 805

[7] Advances in immunology: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (10) : 747 - 755

[8] Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients [J]. TRANSPLANTATION, 2001, 72 (03) : 419 - 422

[9] Utilization of intravenous immunoglobulin to ameliorate alloantibodies in a highly sensitized patient with a cardiac assist device awaiting heart transplantation - Fluorescence-activated cell sorter analysis [J]. TRANSPLANTATION, 1996, 62 (05) : 691 - 693

[10] Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients [J]. TRANSPLANTATION, 2000, 70 (06) : 887 - 895

[1] A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection [J]. TRANSPLANTATION, 2001, 71 (01) : 53 - 58

[2] DeMarco T, 1997, J HEART LUNG TRANSPL, V16, P360

[3] SUPPRESSION OF HLA-SPECIFIC ALLOANTIBODIES BY HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIG) - A POTENTIAL TOOL FOR TRANSPLANTATION OF IMMUNIZED PATIENTS [J]. TRANSPLANTATION, 1993, 56 (02) : 335 - 337

[4] GLOTZ D, 1995, TRANSPLANT P, V27, P1038

[5] JORDAN S C, 1991, Journal of the American Society of Nephrology, V2, P803

[6] Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action [J]. TRANSPLANTATION, 1998, 66 (06) : 800 - 805

[7] Advances in immunology: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (10) : 747 - 755

[8] Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients [J]. TRANSPLANTATION, 2001, 72 (03) : 419 - 422

[9] Utilization of intravenous immunoglobulin to ameliorate alloantibodies in a highly sensitized patient with a cardiac assist device awaiting heart transplantation - Fluorescence-activated cell sorter analysis [J]. TRANSPLANTATION, 1996, 62 (05) : 691 - 693

[10] Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients [J]. TRANSPLANTATION, 2000, 70 (06) : 887 - 895